PMID- 38498197 OWN - NLM STAT- MEDLINE DCOM- 20240401 LR - 20240401 IS - 1435-5604 (Electronic) IS - 0914-8779 (Linking) VI - 42 IP - 2 DP - 2024 Mar TI - Associations of pyrethroid exposure with bone mineral density and osteopenia in adults. PG - 242-252 LID - 10.1007/s00774-024-01499-2 [doi] AB - INTRODUCTION: This study was to investigate the correlations between pyrethroid exposure and bone mineral density (BMD) and osteopenia. MATERIALS AND METHODS: This cross-sectional study included 1389 participants over 50 years of age drawn from the 2007-2010 and 2013-2014 National Health and Nutrition Examination Survey (NHANES). Three pyrethroid metabolites, 3-phenoxybenzoic acid (3-PBA), trans-3-(2,2-dichlorovinyl)-2,2-dimethyl-cyclopropane-1-carboxylic acid (trans-DCCA), and 4-fluoro-3-phenoxybenzoic acid (4-F-3PBA) were used as indicators of pyrethroid exposure. Low BMD was defined as T-score < - 1.0, including osteopenia. Weighted multivariable linear regression analysis or logistic regression analysis was utilized to evaluate the correlation between pyrethroid exposure and BMD and low BMD. Bayesian kernel machine regression (BKMR) model was utilized to analyze the correlation between pyrethroids mixed exposure and low BMD. RESULTS: There were 648 (48.41%) patients with low BMD. In individual pyrethroid metabolite analysis, both tertile 2 and tertile 3 of trans-DCCA were negatively related to total femur, femur neck, and total spine BMD [coefficient (beta) = - 0.041 to - 0.028; all P < 0.05]. Both tertile 2 and tertile 3 of 4-F-3PBA were negatively related to total femur BMD (P < 0.05). Only tertile 2 [odds ratio (OR) = 1.63; 95% CI = 1.07, 2.48] and tertile 3 (OR = 1.65; 95% CI = 1.10, 2.50) of trans-DCCA was correlated with an increased risk of low BMD. The BKMR analysis indicated that there was a positive tendency between mixed pyrethroids exposure and low BMD. CONCLUSION: In conclusion, pyrethroids exposure was negatively correlated with BMD levels, and the associations of pyrethroids with BMD and low BMD varied by specific pyrethroids, pyrethroid concentrations, and bone sites. CI - (c) 2024. The Japanese Society Bone and Mineral Research. FAU - Shen, Zhubin AU - Shen Z AD - Department of Spine Surgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun, 130033, China. shenzb21@mails.jlu.edu.cn. FAU - Zhang, Fengyi AU - Zhang F AD - Department of Spine Surgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun, 130033, China. FAU - Guan, Xiaoqing AU - Guan X AD - Department of Spine Surgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun, 130033, China. FAU - Liu, Zhiming AU - Liu Z AD - Department of Spine Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China. FAU - Zong, Yuan AU - Zong Y AD - Department of Spine Surgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun, 130033, China. FAU - Zhang, Ding AU - Zhang D AD - Department of Spine Surgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun, 130033, China. FAU - Wang, Rui AU - Wang R AD - Department of Toxicology, School of Public, Health of Jilin University, Changchun, 130021, China. FAU - Xue, Qian AU - Xue Q AD - Department of Toxicology, School of Public, Health of Jilin University, Changchun, 130021, China. FAU - Ma, Wenxuan AU - Ma W AD - Department of Toxicology, School of Public, Health of Jilin University, Changchun, 130021, China. FAU - Zhuge, Ruijian AU - Zhuge R AD - Department of Toxicology, School of Public, Health of Jilin University, Changchun, 130021, China. FAU - Guo, Li AU - Guo L AD - Department of Toxicology, School of Public, Health of Jilin University, Changchun, 130021, China. FAU - Yin, Fei AU - Yin F AD - Department of Spine Surgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun, 130033, China. yinfei999@jlu.edu.cn. LA - eng PT - Journal Article DEP - 20240318 PL - Japan TA - J Bone Miner Metab JT - Journal of bone and mineral metabolism JID - 9436705 RN - 0 (Pyrethrins) RN - 69DC2655VH (3-phenoxybenzoic acid) RN - 0 (Insecticides) RN - 2215-77-2 (4-carboxybiphenyl ether) RN - 0 (Benzoates) RN - 0 (Phenyl Ethers) SB - IM MH - Adult MH - Humans MH - Middle Aged MH - *Pyrethrins/adverse effects/analysis/metabolism MH - *Insecticides/adverse effects/analysis/metabolism MH - Nutrition Surveys MH - Cross-Sectional Studies MH - Bone Density MH - Bayes Theorem MH - Environmental Exposure/adverse effects MH - *Bone Diseases, Metabolic/chemically induced/epidemiology MH - *Benzoates MH - *Phenyl Ethers OTO - NOTNLM OT - Bone mineral density OT - Endocrine disruptor chemicals OT - Osteopenia OT - Pyrethroids EDAT- 2024/03/19 00:42 MHDA- 2024/04/01 06:43 CRDT- 2024/03/18 12:15 PHST- 2023/12/09 00:00 [received] PHST- 2024/01/15 00:00 [accepted] PHST- 2024/04/01 06:43 [medline] PHST- 2024/03/19 00:42 [pubmed] PHST- 2024/03/18 12:15 [entrez] AID - 10.1007/s00774-024-01499-2 [pii] AID - 10.1007/s00774-024-01499-2 [doi] PST - ppublish SO - J Bone Miner Metab. 2024 Mar;42(2):242-252. doi: 10.1007/s00774-024-01499-2. Epub 2024 Mar 18.